(Reuters) - Health Canada cautioned on Saturday against the use of malaria drugs hydroxychloroquine and chloroquine to prevent or treat COVID-19.
The Canadian health department said here the two drugs may cause serious side effects, including serious heart rhythm problems. It advised use of the two drugs only if prescribed by a doctor.
The U.S. Food and Drug Administration also cautioned against the use of malaria drugs in COVID-19 patients on Friday.
Reporting by Aakriti Bhalla in Bengaluru; Editing by Kim Coghill
Our Standards: The Thomson Reuters Trust Principles.